-
Johnson & Johnson Management Meetings Leave UBS Reiterating Stock As A Top Pick
Thursday, August 31, 2017 - 12:28pm | 239Read More...After spending the day with Johnson & Johnson (NYSE: JNJ) CEO Alex Gorsky, UBS analysts have reiterated a Buy on the company and called the stock one of the bank's top picks. “We came away from our day of meetings with JNJ Chairman and CEO Alex Gorsky with greater conviction in our...
-
Medtronic Remains A Top Pick At UBS Following HeartWare Deal
Tuesday, June 28, 2016 - 4:30pm | 130Read More...UBS analyst Mike Miksic offered up comments on Medtronic late Monday evening. The research note followed news earlier Monday Medtronic will buy HeartWare International Inc (NASDAQ: HTWR) at $58 per share in cash. The deal "fits strategically, works financially," Miksic highlighted. He...
